Neural transplantation for the treatment of Huntington's disease

European Neurological Review

Volumn 5, Issue 2, 2010, Pages 41-45

  Barker, Roger A ^a   Swain, Rachel A ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Huntington's disease; Neural transplantation; Striatum

Indexed keywords

EID: 82255168969     PISSN: 17583837     EISSN: 17583845     Source Type: Journal    
DOI: 10.17925/ENR.2010.05.02.41     Document Type: Article

References (35)

1. Leegwater-Kim, J, Cha, JJ, The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration, NeuroRX, 2004:1:128-38.
2. Dunnett SB, Functional repair of striatal systems by neural transplants: evidence for circuit reconstruction, Behav Brain Res,1995;66(1-2):133-42.
3. Palfi S, Condé F, Riche D, et al., Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington's disease, Nat Med, 1998;4(8):963-6.
4. Kendall L, Rayment D, Torres E, et al., Functional integration of striatal allografts in a primate model of Huntington's disease, Nat Med, 1998;4(6):727-9.
5. Kopyov OV, Jacques S, Lieberman A, et al., Safety of intrastriatal neurotransplantation for Huntington's disease patients, Exp Neurol, 1998;149(1): 97-108.
6. Ross B, Hoang T, Blüml S, et al., In vivo magnetic resonance spectroscopy of human fetal neural transplants, NMR Biomed, 1999;12(4):221-36.
7. Keene D, Sonnen J, Swanson P, et al., Neural transplantation in Huntington disease: Long-term grafts in two patients, Neurology, 2007;68:2093-8.
8. Keene D, Chang R, Leverenz J, et al., A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesion, Acta Neuropathologica, 2009;117(3):329-38.
9. Bachoud-Lévi AC, Rémy P, Nguyen JP, et al., Motor and cognitive improvements in patients with Huntington's disease after neural transplantation, Lancet, 2000;356(9246):1975-9.
10. Bachoud-Levi AC, Gaura AC, Brugières V, et al., Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study, Lancet Neurol, 2006;5(4):303-09.
11. Rosser AE, Barker R, Harrower RA, et al., Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475, J Neurol Neurosurg Psychiatry, 2002;73:678-85.
12. Gaura S, Maison V, Haddad P, et al., Motor and cognitive improvements in patients with Hunington's disease after neural transplantation, Lancet, 2000:356:1975-79.
13. Krystkowiak P, Gaura V, Labalette M, et al., Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease, PLoS One, 2007;2(1):e166.
14. Hauser RA, Furtado S, Cimino CR, et al., Bilateral human fetal striatal transplantation in Huntington's disease, Neurology, 2002;58(5):687-95.
15. Furtado S, Sossi V, Hauser RA, et al., Positron emission tomography after fetal transplantation in Huntington's disease, Ann Neurol, 2005;58(2):331-7.
16. Freeman TB, Cicchetti F, Hauser RA, et al., Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology, Proc Natl Acad Sci U S A, 2000;97;13877-82.
17. Cicchetti F, Saporta S, Hauser RA, et al., Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration, Proc Natl Acad Sci U S A, 2009;106:12483-8.
18. Capetian P, Knoth R, Maciaczyk J, et al., Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation, Neuroscience, 2009;160(3):661-75.
19. Reuter I, Tai YF, Pavese N, et al., Long term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease, J Neurol Neurosurg Psychiatry, 2008:79;948-95.
20. Gallina P, Paganini M, Di Rita A, et al., Human fetal striatal transplantation in Huntington's disease: a refinement of the stereotactic procedure, Stereotact Funct Neurosurg, 2008;86(5):308-13.
21. Gallina P, Paganini M, Lombardini L, et al., Development of human striatal anlagen after transplantation in a patient with Huntington's disease, Exp Neurol, 2008;213(1):241-4.
22. Gallina P, Paganini M, Lombardini L, et al., Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation, Exp Neurol, 2010;222(1):30-41.
23. Howel L, Byrd L, McDonough A, et al., Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation, Cell Transplant, 2000;9(5):609-22.
24. Watts R, Subramanian T, Freeman A, et al., Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study, Exp Neurol, 1997;147(2):510-7.
25. Olanow CW, Goetz CG, Kordower JH, et al., A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease, Ann Neurol, 2003;54(3):403-14.
26. Krystkowiak P, Gaura V, Labalette M, et al., Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease, PLoS One, 2007;2(1):e166.
27. Riess P, Bareyre FM, Saatman KE, et al., Effects of chronic, post-injury cyclosporine A administration on motor and sensorimotor function following severe, experimental traumatic brain injury, Restor Neurol Neurosci, 2001;18(1):1-8.
28. Watts C, Brasted P, Eagle D, et al., Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease, Exp Neurol, 2000;163(1):85-97.
29. Watts C, Brasted PJ, Dunnett SB, The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces, Cell Transplant, 2000;9(3):395-407.
30. Mendez I, Sanchez-Pernaute R, Cooper O, et al., Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease, Brain, 2005;128(7):1498-510.
31. Hurelbrink CB, Armstrong RJ, Barker RA, et al., Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease, Cell Transplant, 2000;9(6):743-9.
32. van Dellen A, Deacon R, York, D, et al., Anterior cingulate cortical transplantation in transgenic Huntington's disease mice, Brain Res Bull, 2001;56(3-4):313-8.
33. Döbrössy MD, Dunnett SB, Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise, Eur J Neurosci, 2006;24(11):3223-33.
34. Döbrössy M, Dunnett S, Environmental housing and duration of exposure affect striatal graft morphology in a rodent model of Huntington's disease, Cell Transplant, 2008;17(10-11):1125-34.
35. Fink JS, Schumacher JM, Ellias SL, et al., Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results, Cell Transplant, 2000;9(2):273-8.